<ccris>
<DOC>
<DOCNO>1</DOCNO>
<date>20090805</date>
<rln>21086</rln>
<DateRevised>Complete Update on 2009-08-05</DateRevised>
<DateRevised>Complete Update on 2008-03-14</DateRevised>
<DateRevised>Complete Update on 2006-05-04</DateRevised>
<DateRevised>Complete Update on 2005-09-01</DateRevised>
<DateRevised>Complete Update on 2005-03-17</DateRevised>
<DateRevised>Complete Update on 2004-04-23</DateRevised>
<DateRevised>Complete Update on 2004-04-23</DateRevised>
<DateRevised>Complete Update on 02/04/2004, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 06/25/2001, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 09/30/1998, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 02/11/1998, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 10/03/1997, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 06/12/1997, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 04/16/1997, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/10/1996, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 05/03/1996, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 11/02/1995, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 10/02/1995, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 04/07/1995, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 03/03/1995, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 02/02/1995, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 01/05/1995, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 09/08/1994, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 08/01/1994, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 05/05/1994, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 03/07/1994, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/03/1993, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 03/19/1993, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 02/16/1993, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/15/1992, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 06/05/1992, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 07/23/1991, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 10/19/1989, 4 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/31/1985</DateRevised>
<NameOfSubstance>2-ACETYLAMINOFLUORENE</NameOfSubstance>
<CASRegistryNumber>53-96-3</CASRegistryNumber>
<dtyp>Carcinogenicity</dtyp>
<dtyp>Tumor Promotion</dtyp>
<dtyp>Mutagenicity</dtyp>
<cstu>
<specc>DOG</specc>
<stsxc>BEAGLE</stsxc>
<routc>ORAL</routc>
<dosec>8.3-10.9 MG/KG/D (AVE DAILY INTAKE) FOR 68.5-91 MO (TOTAL DOSE: 90-198 G)</dosec>
<tstlc>LIVER: CARCINOMA; URINARY BLADDER: PAPILLOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>HAMSTER</specc>
<stsxc>SYRIAN</stsxc>
<routc>ORAL</routc>
<dosec>5 MG FOR 22 WK THEN 15 MG FOR 4 WK, THEN 10 MG 2/WK AFTER 42 WK</dosec>
<tstlc>URINARY BLADDER: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. 72-73 356]</ref></cstu>
<cstu><specc>HAMSTER</specc>
<stsxc>SYRIAN/ MALE, FEMALE</stsxc>
<routc>INTRAPERITONEAL, ORAL</routc>
<dosec>5 MG/100 G 3/WK FOR 3 WK, THEN 0.06% IN DIET</dosec>
<tstlc>URINARY BLADDER; LIVER: CHOLANGIOCARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. 72-73 356]</ref></cstu>
<cstu><specc>HAMSTER</specc>
<stsxc>SYRIAN/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.025% IN DIET FOR LIFE</dosec>
<tstlc>LIVER: INTRAHEPATIC BILE DUCT CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. 68-69 361]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>CBA/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>3 MG/MOUSE 2/WK</dosec>
<tstlc>MAMMARY GLAND; URINARY BLADDER; LIVER</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Y-47 439][WEISBURGER,EK AND WEISBURGER,JH; CHEMISTRY, CARCINOGENICITY, AND METABOLISM OF 2-FLUORENAMINE AND RELATED COMPOUNDS; ADV. CANCER RES. 5:356-357, 1958, ]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>STRAIN-IF/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>3 MG/MOUSE 2/WK</dosec>
<tstlc>URINARY BLADDER; LIVER; MAMMARY GLAND</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Y-47 439][WEISBURGER,EK AND WEISBURGER,JH; CHEMISTRY, CARCINOGENICITY, AND METABOLISM OF 2-FLUORENAMINE AND RELATED COMPOUNDS; ADV. CANCER RES. 5:356-357, 1958, ]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>R-III/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>3 MG/MOUSE 2/WK</dosec>
<tstlc>URINARY BLADDER; LIVER</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Y-47 439][WEISBURGER,EK AND WEISBURGER,JH; CHEMISTRY, CARCINOGENICITY, AND METABOLISM OF 2-FLUORENAMINE AND RELATED COMPOUNDS; ADV. CANCER RES. 5:356-357, 1958, ]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>STRAIN-A/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>3 MG/MOUSE 2/WK</dosec>
<tstlc>URINARY BLADDER</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Y-47 439][WEISBURGER,EK AND WEISBURGER,JH; CHEMISTRY, CARCINOGENICITY, AND METABOLISM OF 2-FLUORENAMINE AND RELATED COMPOUNDS; ADV. CANCER RES. 5:356-357, 1958, ]</ref></cstu>
<cstu><specc>RABBIT</specc>
<stsxc>NZW/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>100 MG IN 1 ML CORN OIL 2/WK FOR LIFE</dosec>
<tstlc>URINARY BLADDER: TRANSITIONAL CELL TUMOR; KIDNEY: TRANSITIONAL CELL TUMOR</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. 68-69 361]</ref></cstu>
<cstu><specc>RABBIT</specc>
<stsxc>NZW/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>100 MG 2/WK (TOTAL DOSE 21-52 G AS POWDER)</dosec>
<tstlc>URINARY BLADDER: PAPILLOMA, ADENOCARCINOMA; URETER: PAPILLOMA, ADENOCARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>ALBINO/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.125% IN DIET</dosec>
<tstlc>URINARY BLADDER: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Y-47 439]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>ALBINO/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0.018; 0.036% IN DIET FOR 90 DAYS</dosec>
<tstlc>LIVER: HEPATOMA; EAR (DUCT); INTESTINES (SMALL)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>ALBINO/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.036% IN DIET FOR 8 MO</dosec>
<tstlc>LIVER: HEPATOMA; MAMMARY GLAND; EAR (DUCT)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>BUFFALO/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.05% IN DIET FOR 23 WK (580 MG/RAT)</dosec>
<tstlc>LIVER: HEPATOMA; EAR (DUCT): CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>STRAIN-CD/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>80; 250 PPM IN DIET FOR 78 WK (LOW DOSE) OR 50 WK (HIGH DOSE)</dosec>
<tstlc>LIVER: NEOPLASTIC NODULE, HEPATOCELLULAR CARCINOMA; MAMMARY GLAND: ADENOCARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[WEISBURGER,EK, ULLAND,BM, NAM,J-M, GART,JJ AND WEISBURGER,JH; CARCINOGENICITY TESTS OF CERTAIN ENVIRONMENTAL AND INDUSTRIAL CHEMICALS; J. NATL. CANCER INST. 67:75-88, 1981]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>STRAIN-CD/MALE</stsxc>
<routc>ORAL</routc>
<dosec>80; 250 PPM IN DIET FOR 78 WK (LOW DOSE) OR 50 WK (HIGH DOSE)</dosec>
<tstlc>LIVER: HEPATOCELLULAR CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[WEISBURGER,EK, ULLAND,BM, NAM,J-M, GART,JJ AND WEISBURGER,JH; CARCINOGENICITY TESTS OF CERTAIN ENVIRONMENTAL AND INDUSTRIAL CHEMICALS; J. NATL. CANCER INST. 67:75-88, 1981]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.03% IN DIET</dosec>
<tstlc>EYE</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>1.62 MMOL/KG DIET FOR 8 MO</dosec>
<tstlc>MAMMARY GLAND; EAR (DUCT); INTESTINES (SMALL)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0.06% IN DIET FOR 3 WK, THEN CONTROL DIET FOR 1 WK, REPEATED 3X</dosec>
<tstlc>TESTES: MESOTHELIOMA; LIVER: HEPATOCELLULAR CARCINOMA, CHOLANGIOCARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[CABRAL,JRP AND NEAL,GE; TESTICULAR MESOTHELIOMAS IN RATS EXPOSED TO N-2-FLUORENYLACETAMIDE (FAA); TUMORI 69:195-199, 1983]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>HOLTZMAN/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>1.62 MMOL/KG IN DIET</dosec>
<tstlc>MAMMARY GLAND; EAR (DUCT); INTESTINES (SMALL)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>HOLTZMAN/MALE</stsxc>
<routc>ORAL</routc>
<dosec>1.62 MMOL/KG IN DIET</dosec>
<tstlc>LIVER; EAR (DUCT); INTESTINES (SMALL)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>LONG-EVANS/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>IN DIET</dosec>
<tstlc>EAR (AUDITORY CANAL): SQUAMOUS CELL CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>MALE</stsxc>
<routc>ORAL</routc>
<dosec>1.62 MMOL/KG IN DIET FOR 8 MO</dosec>
<tstlc>LIVER: HEPATOMA; INTESTINES (SMALL); EAR (DUCT)</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>PIEBALD/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.03% IN DIET</dosec>
<tstlc>MAMMARY GLAND: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>PIEBALD/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>4 MG DAILY IN DIET FOR 25 WK</dosec>
<tstlc>LIVER: HEPATOMA; EAR (DUCT): CARCINOMA; INTESTINES: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>SHERMAN/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.03% IN DIET FOR LIFE</dosec>
<tstlc>LIVER: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>SPRAGUE-DAWLEY/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>300 MG/KG IN SEMI-PURIFIED OR STOCK DIET</dosec>
<tstlc>EAR (DUCT): CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>SPRAGUE-DAWLEY/FEMALE</stsxc>
<routc>INTRAPERITONEAL</routc>
<dosec>1 MG/0.1 ML 3/WK FOR 4 WK (TOTAL DOSE 0.17 MMOL/RAT)</dosec>
<tstlc>MAMMARY GLAND: ADENOCARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. 72-73 356]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>WISTAR/MALE</stsxc>
<routc>DERMAL</routc>
<dosec>IN ACETONE</dosec>
<tstlc>LIVER: HEPATOMA; INTESTINES: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>WISTAR/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.07% IN DIET</dosec>
<tstlc>LIVER: HEPATOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>WISTAR/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.03% IN DIET FOR LIFE</dosec>
<tstlc>LIVER: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>SHEFFIELD/ MALE, FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>4 MG DAILY IN DIET FOR 25 WK</dosec>
<tstlc>LIVER: HEPATOMA; EAR (DUCT): CARCINOMA; INTESTINES: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>AES/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>300 MG/KG IN SEMI-PURIFIED OR STOCK DIET</dosec>
<tstlc>EAR (DUCT): CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>PIEBALD/MALE</stsxc>
<routc>DERMAL</routc>
<dosec>IN ACETONE</dosec>
<tstlc>LIVER: HEPATOMA; INTESTINES: CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[U.S. PUBLIC HEALTH SERVICE PUBLICATION 149;SURVEY OF COMPOUNDS WHICH HAVE BEEN TESTED FOR CARCINOGENIC ACTIVITY; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT PRINTING OFFICE, WASHINGTON, D.C., p. Suppl 1 497]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>BALB/C/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 75; 100; 150 PPM IN DIET UP TO 33 MO (STUDY DURATION: 33 MO)</dosec>
<tstlc>LIVER: HEPATOCELLULAR ADENOMA OR CARCINOMA; BLADDER: TRANSITIONAL CELL CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[SHINOHARA,Y AND FRITH,CH; CORRELATION BETWEEN SPONTANEOUS AND EXPERIMENTALLY INDUCED TUMORS IN FEMALE BALB/C MICE IN A LARGE 2-ACETYLAMINOFLUORENE STUDY; J. ENVIRON. PATHOL. TOXICOL. ONCOL. 6(5-6):85-96, 1986]</ref></cstu>
<cstu><specc>FISH</specc>
<stsxc>GUPPY/ MALE,  FEMALE</stsxc>
<routc>IMMERSION</routc>
<dosec>0; 1 MG/L IN WELL WATER FOR 1 6 HR EXPOSURE OR FOR 1,2,3 OR 4 12 HR EXPOSURES, MULTIPLE EXPOSURES GIVEN AT WEEKLY INTERVALS (STUDY DURATION: 52 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[JAMES,MO, HAWKINS,WE AND WALKER,WW; PHASE 1 AND PHASE 2 BIOTRANSFORMATION AND CARCINOGENICITY OF 2-ACETYLAMINOFLUORENE IN MEDAKA AND GUPPY; AQUAT. TOXICOL. 28(1-2):79-95, 1994]</ref></cstu>
<cstu><specc>FISH</specc>
<stsxc>MEDAKA/ MALE, FEMALE</stsxc>
<routc>IMMERSION</routc>
<dosec>0; 1 MG/L IN WELL WATER FOR 1 6 HR EXPOSURE OR FOR 1,2,3 OR 4 12 HR EXPOSURES, MULTIPLE EXPOSURES GIVEN AT WEEKLY INTERVALS (STUDY DURATION: 52 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[JAMES,MO, HAWKINS,WE AND WALKER,WW; PHASE 1 AND PHASE 2 BIOTRANSFORMATION AND CARCINOGENICITY OF 2-ACETYLAMINOFLUORENE IN MEDAKA AND GUPPY; AQUAT. TOXICOL. 28(1-2):79-95, 1994]</ref></cstu>
<cstu><specc>FISH</specc>
<stsxc>MEDAKA/ MALE, FEMALE</stsxc>
<routc>IMMERSION</routc>
<dosec>0; 1 MG/L IN WELL WATER FOR 7 D CONTINUOUS EXPOSURE, SOLUTIONS RENEWED EVERY 24 HR (STUDY DURATION: 52 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[JAMES,MO, HAWKINS,WE AND WALKER,WW; PHASE 1 AND PHASE 2 BIOTRANSFORMATION AND CARCINOGENICITY OF 2-ACETYLAMINOFLUORENE IN MEDAKA AND GUPPY; AQUAT. TOXICOL. 28(1-2):79-95, 1994]</ref></cstu>
<cstu><specc>FISH</specc>
<stsxc>GUPPY/ MALE, FEMALE</stsxc>
<routc>IMMERSION</routc>
<dosec>0; 1 MG/L IN WELL WATER FOR 7 D CONTINUOUS EXPOSURE, SOLUTIONS RENEWED EVERY 24 HR (STUDY DURATION: 52 WK)</dosec>
<tstlc>LIVER: TUMOR</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[JAMES,MO, HAWKINS,WE AND WALKER,WW; PHASE 1 AND PHASE 2 BIOTRANSFORMATION AND CARCINOGENICITY OF 2-ACETYLAMINOFLUORENE IN MEDAKA AND GUPPY; AQUAT. TOXICOL. 28(1-2):79-95, 1994]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>EU-PIM-1/MALE</stsxc>
<routc>GAVAGE</routc>
<dosec>0; 25; 100 MG/KG 1/D FOR 38 WK (STUDY DURATION: 38 WK)</dosec>
<tstlc>LYMPHATIC SYSTEM: LYMPHOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[STORER,RD, CARTWRIGHT,ME, COOK,WO, SOPER,KA AND NICOLS,WW; SHORT-TERM CARCINOGENESIS BIOASSAY OF GENOTOXIC PROCARCINOGENS IN PM TRANSGENIC MICE; CARCINOGENESIS 16(2):285-293, 1995]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>EU-PIM-1/FEMALE</stsxc>
<routc>GAVAGE</routc>
<dosec>0; 25; 100 MG/KG 1/D FOR 38 WK (STUDY DURATION: 38 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[STORER,RD, CARTWRIGHT,ME, COOK,WO, SOPER,KA AND NICOLS,WW; SHORT-TERM CARCINOGENESIS BIOASSAY OF GENOTOXIC PROCARCINOGENS IN PM TRANSGENIC MICE; CARCINOGENESIS 16(2):285-293, 1995]</ref></cstu>
<tstu>
<spect>RAT</spect>
<stsxt>WISTAR/MALE</stsxt>
<rtprt>ORAL</rtprt>
<doprt>0; 0.02% IN DIET FOR 1 MO BEGINNING 1 WK POST CARCINOGEN DOSE (STUDY DURATION: 8 MO)</doprt>
<crcnt>DIETHYLNITROSAMINE ; 55-18-5</crcnt>
<rtcat>INTRAPERITONEAL</rtcat>
<docat>50 MG/KG ONCE 24 HR AFTER 2/3 PARTIAL HEPATECTOMY</docat>
<tttlt>LIVER: CARCINOMA</tttlt>
<ref>[GERLYNG,P, GROTMOL,T AND SEGLEN,PO; EFFECT OF 4-ACETYLAMINOFLUORENE AND OTHER TUMOR PROMOTERS ON HEPATOCELLULAR GROWTH AND BINUCLEATION; CARCINOGENESIS 15(2):371-379, 1994]</ref></tstu>
<tstu><spect>RAT</spect>
<stsxt>SPRAGUE-DAWLEY/MALE</stsxt>
<rtprt>GAVAGE</rtprt>
<doprt>0; 0.05 MMOL/KG BW IN POLYETHYLENE GLYCOL FOR 5 D BEGINNING 1 WK POST CARCINOGEN DOSE, 70% PARTIAL HEPATECTOMY PERFORMED 3 D AFTER FIFTH DOSE FOLLOWED 2 D LATER BY 5 D OF AGENT TREATMENT THEN 2 WK REST FOLLOWED BY ANOTHER 5 D SERIES OF AGENT TREATMENTS (STUDY DURATION: 9.2 MO)</doprt>
<crcnt>DIETHYLNITROSAMINE ; 55-18-5</crcnt>
<rtcat>INTRAPERITONEAL</rtcat>
<docat>200 MG/KG BW IN 0.9% SALINE ONCE</docat>
<tttlt>LIVER: HEPATOCELLULAR CARCINOMA</tttlt>
<ref>[VIJAYARAGHAVAN,P, MALEJKA-GIGANTI,D AND SHINOZUKA,H; PROMOTING ACTIVITIES OF THE C-9 OXIDIZED METABOLITES OF N-2-FLUORENYLACETAMIDE IN LIVER CARCINOGENESIS IN THE RAT; INT. J. ONCOL. 7(2):287-294, 1995]</ref></tstu>
<mstu>
<tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, KC500 OR PHENOBARBITAL</matvm>
<methm>LIQUID SUSPENSION</methm>
<rsltm>POSITIVE</rsltm>
<ref>[RINKUS,SJ AND LEGATOR,MS; CHEMICAL CHARACTERIZATION OF 465 KNOWN OR SUSPECTED CARCINOGENS AND THEIR CORRELATION WITH MUTAGENIC ACTIVITY IN THE SALMONELLA TYPHIMURIUM SYSTEM; CANCER RES. 39:3289-3318, 1979][SUGIMURA,T, SATO,S, NAGAO,M, YAHAGI,T, MATSUSHIMA,T, SEINO,Y, TAKEUCHI,M AND KAWAC HI,T; OVERLAPPING OF CARCINOGENS AND MUTAGENS; IN: MAGEE,PN, TAKAYAMA,S, SUGIMURA,T AND MATSUSHIMA,T (EDS.), FUNDAMENTALS IN CANCER PREVENTION, UNIVERSITY PARK PRESS, BALTIMORE, MARYLAND, 1976, PP. 191-215]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, PHENOBARBITAL</matvm>
<methm>STANDARD PLATE</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MCCANN,J, CHOI,E, YAMASAKI,E AND AMES,BN; DETECTION OF CARCINOGENS AS MUTAGENS IN THE SALMONELLA/MICROSOME TEST: ASSAY OF 300 CHEMICALS; PROC. NATL. ACAD. SCI. USA 72(12):5135-5139, 1975]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, PHENOBARBITAL</matvm>
<methm>STANDARD PLATE</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MCCANN,J, CHOI,E, YAMASAKI,E AND AMES,BN; DETECTION OF CARCINOGENS AS MUTAGENS IN THE SALMONELLA/MICROSOME TEST: ASSAY OF 300 CHEMICALS; PROC. NATL. ACAD. SCI. USA 72(12):5135-5139, 1975]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, KC500 OR PHENOBARBITAL</matvm>
<methm>LIQUID SUSPENSION</methm>
<rsltm>POSITIVE</rsltm>
<ref>[RINKUS,SJ AND LEGATOR,MS; CHEMICAL CHARACTERIZATION OF 465 KNOWN OR SUSPECTED CARCINOGENS AND THEIR CORRELATION WITH MUTAGENIC ACTIVITY IN THE SALMONELLA TYPHIMURIUM SYSTEM; CANCER RES. 39:3289-3318, 1979][SUGIMURA,T, SATO,S, NAGAO,M, YAHAGI,T, MATSUSHIMA,T, SEINO,Y, TAKEUCHI,M AND KAWAC HI,T; OVERLAPPING OF CARCINOGENS AND MUTAGENS; IN: MAGEE,PN, TAKAYAMA,S, SUGIMURA,T AND MATSUSHIMA,T (EDS.), FUNDAMENTALS IN CANCER PREVENTION, UNIVERSITY PARK PRESS, BALTIMORE, MARYLAND, 1976, PP. 191-215]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, PHENOBARBITAL</matvm>
<methm>STANDARD PLATE</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MCCANN,J, CHOI,E, YAMASAKI,E AND AMES,BN; DETECTION OF CARCINOGENS AS MUTAGENS IN THE SALMONELLA/MICROSOME TEST: ASSAY OF 300 CHEMICALS; PROC. NATL. ACAD. SCI. USA 72(12):5135-5139, 1975]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, PHENOBARBITAL</matvm>
<methm>STANDARD PLATE</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MCCANN,J, CHOI,E, YAMASAKI,E AND AMES,BN; DETECTION OF CARCINOGENS AS MUTAGENS IN THE SALMONELLA/MICROSOME TEST: ASSAY OF 300 CHEMICALS; PROC. NATL. ACAD. SCI. USA 72(12):5135-5139, 1975]</ref></mstu>
<mstu><tsstm>MOUSE LYMPHOMA</tsstm>
<indcm>L5178Y (TK+/TK-)</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SUSPENSION/PLATE</methm>
<rsltm>POSITIVE</rsltm>
<ref>[CLIVE,D, MCCUEN,R, SPECTOR,JFS, PIPER,C AND MAVOURNIN,KH; SPECIFIC GENE MUTATIONS IN L5178Y CELLS IN CULTURE: A REPORT OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY GENE-TOX PROGRAM; MUTAT. RES. 115:225-251, 1983]</ref></mstu>
<mstu><tsstm>UDS HUMAN FIBROBLASTS</tsstm>
<indcm>THY INCORP (NON-S-PHASE)</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, CASCIANO,DA, MELTZ,ML, ROBINSON,DE, SAN,RHC, WILLIAMS,GM AND VON HALLE,ES; UNSCHEDULED DNA SYNTHESIS TESTS: A REPORT OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY GENE-TOX PROGRAM; MUTAT. RES. 123:363-410, 1983]</ref></mstu>
<mstu><tsstm>UDS RODENT HEPATOCYTES</tsstm>
<indcm>THY INCORP (NON-S-PHASE)</indcm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, CASCIANO,DA, MELTZ,ML, ROBINSON,DE, SAN,RHC, WILLIAMS,GM AND VON HALLE,ES; UNSCHEDULED DNA SYNTHESIS TESTS: A REPORT OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY GENE-TOX PROGRAM; MUTAT. RES. 123:363-410, 1983]</ref></mstu>
<mstu><tsstm>UDS RODENT HEPATOCYTES</tsstm>
<indcm>THY INCORP (NON-S-PHASE)</indcm>
<methm>AUTORADIOGRAPHY</methm>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, CASCIANO,DA, MELTZ,ML, ROBINSON,DE, SAN,RHC, WILLIAMS,GM AND VON HALLE,ES; UNSCHEDULED DNA SYNTHESIS TESTS: A REPORT OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY GENE-TOX PROGRAM; MUTAT. RES. 123:363-410, 1983]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA97</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA97</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BRAMS,A, BUCHET,JP, CRUTZEN-FAYT,MC, DE MEESTER,C, LAUWERYS,R AND LEONARD,A; A COMPARATIVE STUDY, WITH 40 CHEMICALS, OF THE EFFICIENCY OF THE SALMONELLA ASSAY AND THE SOS CHROMOTEST (KIT PROCEDURE); TOXICOL. LETT. 38(1-2):123-133, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1.5-50 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[CREBELLI,R AND IORIO,MA; CHEMISTRY AND IN VITRO MUTAGENICITY OF 2-AMINOFLUORENE DERIVATIVES; CHEM.-BIOL. INTERACT. 54(1):71-83, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, BLADDER, S-9, PCB</matvm>
<methm>FLUCTUATION TEST</methm>
<dosem>0-20 UG/ML</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HAYASHI,K, MATSUKUBO,K, NAGASHIMA,T, ISHIKAWA,T, HASHIDA,C AND SHIMIZU,H; FLUCTUATION TEST IN RAT BLADDER S9-MEDIATED MUTAGENESIS OF SEVERAL CHEMICALS; NIPPON EISEIGAKU ZASSHI 43(4):934-9, 1988]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, BLADDER, S-9, PCB</matvm>
<methm>FLUCTUATION TEST</methm>
<dosem>0-20 UG/ML</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HAYASHI,K, MATSUKUBO,K, NAGASHIMA,T, ISHIKAWA,T, HASHIDA,C AND SHIMIZU,H; FLUCTUATION TEST IN RAT BLADDER S9-MEDIATED MUTAGENESIS OF SEVERAL CHEMICALS; NIPPON EISEIGAKU ZASSHI 43(4):934-9, 1988]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HUMAN, RED BLOOD CELL, CYTOSOL</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-50 UG/PLATE (TEST MATERIAL SOLVENT:DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VANBOGAERT,M, CRUTZEN-FAYT,MC AND STECCA,C; ACTIVATION OF SOME AROMATIC AMINES TO MUTAGENIC PRODUCTS BY HUMAN RED BLOOD CELL CYTOSOL; MUTAT. RES. 263(4):249-255, 1991]</ref></mstu>
<mstu><tsstm>UDS RODENT HEPATOCYTES</tsstm>
<indcm>THY INCORP (NON-S-PHASE)</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>0.1-1000 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[LEFEVRE,PA AND ASHBY,J; ACTIVITY OF 2-ACETYLAMINOFLUORENE AS A UDS INDUCTING AGENT IN B6C3F1 MOUSE HEPATOCYTES IN VITRO;CELL BIOL. TOXICOL. 6(1):15-21, 1990]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RABBIT, LIVER, MICROSOMAL FRACTION</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1.2-200 NMOL/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ROBERTSON,IGC; THE IMPORTANCE OF 2-AMINOFLUORENE IN THE MUTAGENIC ACTIVATION OF 2-ACETYLAMINOFLUORENE; MUTAT. RES. 175(3):153-157, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RABBIT, LUNG, MICROSOMAL FRACTION</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1.2-200 NMOL/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ROBERTSON,IGC; THE IMPORTANCE OF 2-AMINOFLUORENE IN THE MUTAGENIC ACTIVATION OF 2-ACETYLAMINOFLUORENE; MUTAT. RES. 175(3):153-157, 1986]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER V-79</tsstm>
<indcm>V-79/6-THIOGUANINE</indcm>
<matvm>NONE</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>0.03-0.15 MILLIMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[FASSINA,G, ABBONDANDOLO,A, MARIANI,L, TANINGHER,M AND PARODI,S; MUTAGENICITY IN V79 CELLS DOES NOT CORRELATE WITH CARCINOGENITY IN SMALL RODENTS FOR 12 AROMATIC AMINES; J. TOXICOL. ENVIRON. HEALTH 29(1):109-130, 1990]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER V-79</tsstm>
<indcm>V-79/6-THIOGUANINE</indcm>
<matvm>RAT, LIVER, S-9, PHENOBARBITAL AND BETA-NAPHTHOFLAVONE</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>0.01-0.05 MILLIMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[FASSINA,G, ABBONDANDOLO,A, MARIANI,L, TANINGHER,M AND PARODI,S; MUTAGENICITY IN V79 CELLS DOES NOT CORRELATE WITH CARCINOGENITY IN SMALL RODENTS FOR 12 AROMATIC AMINES; J. TOXICOL. ENVIRON. HEALTH 29(1):109-130, 1990]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER V-79</tsstm>
<indcm>V-79/6-THIOGUANINE</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>0.01-0.05 MILLIMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[FASSINA,G, ABBONDANDOLO,A, MARIANI,L, TANINGHER,M AND PARODI,S; MUTAGENICITY IN V79 CELLS DOES NOT CORRELATE WITH CARCINOGENITY IN SMALL RODENTS FOR 12 AROMATIC AMINES; J. TOXICOL. ENVIRON. HEALTH 29(1):109-130, 1990]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER OVARY</tsstm>
<indcm>CHO-K1-BH4 (HGPRT)</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>5-200 UG/ML</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[OBERLY,TJ, REXROAT,MA, BEWSEY,BJ, RICHARDSON,KK AND MICHAELIS,KC; AN EVALUATION OF THE CHO/HGPRT MUTATION ASSAY INVOLVING SUSPENSION CULTURES AND SOFT AGAR CLONING: RESULTS FOR 33 CHEMICALS; ENVIRON. MOL. MUTAGEN. 16(4):260-271, 1990]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BROWN,JP AND BROWN,RJ; MUTAGENESIS BY 9,10-ANTHRAQUINONE DERIVATIVES AND RELATED COMPOUNDS IN SALMONELLA TYPHIMURIUM; MUTAT. RES. 40:203-224, 1976]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HUMAN, FETAL LIVER, S-9</matvm>
<dosem>10 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[AUNE,T, HAUGEN,A AND DYBING,E; METABOLISM AND MUTAGENICITY OF AROMATIC AMINES BY HUMAN FETAL LIVER; ARCH. TOXICOL. 57(2):136-138, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.3-333.3 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: I. TESTS WITH SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI USING A STANDARDIZED PROTOCOL; ENVIRON. MOL. MUTAGEN. 6(SUPPL. 2):1-254, 1984]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.3-333.3 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: I. TESTS WITH SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI USING A STANDARDIZED PROTOCOL; ENVIRON. MOL. MUTAGEN. 6(SUPPL. 2):1-254, 1984]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.3-333.3 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: I. TESTS WITH SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI USING A STANDARDIZED PROTOCOL; ENVIRON. MOL. MUTAGEN. 6(SUPPL. 2):1-254, 1984]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.3-333.3 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: I. TESTS WITH SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI USING A STANDARDIZED PROTOCOL; ENVIRON. MOL. MUTAGEN. 6(SUPPL. 2):1-254, 1984]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.3-333.3 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: I. TESTS WITH SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI USING A STANDARDIZED PROTOCOL; ENVIRON. MOL. MUTAGEN. 6(SUPPL. 2):1-254, 1984]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>PREINCUBATION</methm>
<dosem>1-50 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ASHBY,J, LEFEVRE,PA, BURLINSON,B AND PENMAN,MG; AN ASSESSMENT OF THE IN VIVO RAT HEPATOCYTE DNA-REPAIR ASSAY; MUTAT. RES. 156(1-2):1-18, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>PREINCUBATION</methm>
<dosem>1-50 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ASHBY,J, LEFEVRE,PA, BURLINSON,B AND PENMAN,MG; AN ASSESSMENT OF THE IN VIVO RAT HEPATOCYTE DNA-REPAIR ASSAY; MUTAT. RES. 156(1-2):1-18, 1985]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>IN VIVO</methm>
<dosem>50-100 MG/KG</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ASHBY,J, LEFEVRE,PA, BURLINSON,B AND PENMAN,MG; AN ASSESSMENT OF THE IN VIVO RAT HEPATOCYTE DNA-REPAIR ASSAY; MUTAT. RES. 156(1-2):1-18, 1985]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>0-1000 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[ASHBY,J, LEFEVRE,PA, BURLINSON,B AND PENMAN,MG; AN ASSESSMENT OF THE IN VIVO RAT HEPATOCYTE DNA-REPAIR ASSAY; MUTAT. RES. 156(1-2):1-18, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>GUINEA PIG, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-5 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, HEPATOCYTES</matvm>
<dosem>10-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, HEPATOCYTES</matvm>
<dosem>10-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, HEPATOCYTES</matvm>
<dosem>10-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>GUINEA PIG, LIVER, HEPATOCYTES</matvm>
<dosem>10-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<dosem>0.1-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>UDS MOUSE HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<dosem>10-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>UDS HAMSTER HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<dosem>0.1-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>UDS GUINEA PIG HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<dosem>0.1-500 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[HOLME,JA AND SOEDERLUND,EJ; SPECIES DIFFERENCES IN THE CYTOTOXIC AND GENOTOXIC EFFECTS OF 2-ACETYLAMINOFLUORENE AND ITS PRIMARY METABOLITES 2-AMINOFLUORENE AND N-HYDROXY-2-ACETYLAMINOFLUORENE; CARCINOGENESIS 6(3):421-425, 1985]</ref></mstu>
<mstu><tsstm>MOUSE LYMPHOMA</tsstm>
<indcm>L5178Y (TK+/TK-)</indcm>
<matvm>NONE</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>15.6-1000 UG/ML (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, RUDD,CJ AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT SRI INTERNATIONAL; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):37-101, 1988][MYHR,BC AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT LITTON BIONETICS, INC.; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):103-194, 1988]</ref></mstu>
<mstu><tsstm>MOUSE LYMPHOMA</tsstm>
<indcm>L5178Y (TK+/TK-)</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>6.9-140 UG/ML (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, RUDD,CJ AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT SRI INTERNATIONAL; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):37-101, 1988][MYHR,BC AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT LITTON BIONETICS, INC.; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):103-194, 1988]</ref></mstu>
<mstu><tsstm>MOUSE LYMPHOMA</tsstm>
<indcm>L5178Y (TK+/TK-)</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>SUSPENSION/PLATE</methm>
<dosem>2.4-1000 UG/ML (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[MITCHELL,AD, RUDD,CJ AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT SRI INTERNATIONAL; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):37-101, 1988][MYHR,BC AND CASPARY,WJ; EVALUATION OF THE L5178Y MOUSE LYMPHOMA CELL MUTAGENESIS ASSAY: INTRALABORATORY RESULTS FOR SIXTY-THREE CODED CHEMICALS TESTED AT LITTON BIONETICS, INC.; ENVIRON. MOL. MUTAGEN. 12(SUPPL. 13):103-194, 1988]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, ACRYLAMIDE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>20-80 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[EL-DIN,AYG, AL-MASKATI,HA, MOHAMED,AYA AND DAIRI,MG; ACRYLAMIDE AS AN INDUCER OF METABOLIC ACTIVATION SYSTEM (S9) IN RATS; MUTAT. RES. 300(2):91-97, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, ACRYLAMIDE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>20-80 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[EL-DIN,AYG, AL-MASKATI,HA, MOHAMED,AYA AND DAIRI,MG; ACRYLAMIDE AS AN INDUCER OF METABOLIC ACTIVATION SYSTEM (S9) IN RATS; MUTAT. RES. 300(2):91-97, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, MICROSOMES, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-40 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, MICROSOMES</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-40 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, MICROSOMES, 2-ACETYLAMINOFLUORENE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-40 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, CYTOSOL, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-100 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, CYTOSOL</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-100 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, CYTOSOL, 2-ACETYLAMINOFLUORENE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-100 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[IOANNIDES,C, CHEUNG,YL, WILSON,J, LEWIS,DFV AND GRAY,TJB; THE MUTAGENICITY AND INTERACTIONS OF 2- AND 4-(ACETYLAMINO)FLUORENE WITH CYTOCHROME P450 AND THE AROMATIC HYDROCARBON RECEPTOR MAY EXPLAIN THE DIFFERENCE IN THEIR CARCINOGENIC POTENCY; CHEM. RES. TOXICOL. 6(4):535-541, 1993]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>BROMODEOXYURIDINE INCORP</indcm>
<matvm>NONE</matvm>
<methm>FLOW CYTOMETRIC ANALYSIS</methm>
<dosem>0.0025-2.5 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[SELDEN,JR, DOLBEARE,F, CLAIR,JH, MILLER,JE, MCGETTIGAN,K, DIJOHN,JA, DYSART,GR AND DELUCA,JG; VALIDATION OF A FLOW CYTOMETRIC IN VITRO DNA REPAIR (UDS) ASSAY IN RAT HEPATOCYTES; MUTAT. RES. 315(2):147-167, 1994]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>0.0025-2.5 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[SELDEN,JR, DOLBEARE,F, CLAIR,JH, MILLER,JE, MCGETTIGAN,K, DIJOHN,JA, DYSART,GR AND DELUCA,JG; VALIDATION OF A FLOW CYTOMETRIC IN VITRO DNA REPAIR (UDS) ASSAY IN RAT HEPATOCYTES; MUTAT. RES. 315(2):147-167, 1994]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY (SERUM-FREE MEDIA)</methm>
<dosem>0.05-1 UG/ML (TEST MATERIAL SOLVENT: WILLIAMS E MEDIUM)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[PARTON,JW, YOUNT,DJ AND GARRIOTT,ML; IMPROVED SENSITIVITY OF THE UNSCHEDULED DNA SYNTHESIS ASSAY IN PRIMARY RAT HEPATOCYTES FOLLOWING CULTURE IN SERUM-FREE DEFINED MEDIA; ENVIRON. MOL. MUTAGEN. 26(2):147-154, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>1-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>SPIRAL ASSAY</methm>
<dosem>3-624 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DIEHL,M AND FORT,F; SPIRAL SALMONELLA ASSAY: VALIDATION AGAINST THE STANDARD POUR-PLATE ASSAY; ENVIRON. MOL. MUTAGEN. 27(3):227-236, 1996]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HUMAN, HEPATOMA CELLS</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HUMAN, HEPATOMA CELLS, BENZO[A]ANTHRACENE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>YG1024</indcm>
<matvm>HUMAN, HEPATOMA CELLS</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>YG1024</indcm>
<matvm>HUMAN, HEPATOMA CELLS, BENZO[A]ANTHRACENE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>YG1024</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ400</indcm>
<matvm>HUMAN, HEPATOMA CELLS</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ400</indcm>
<matvm>HUMAN, HEPATOMA CELLS, BENZO[A]ANTHRACENE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ400</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ460</indcm>
<matvm>HUMAN, HEPATOMA CELLS</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ460</indcm>
<matvm>HUMAN, HEPATOMA CELLS, BENZO[A]ANTHRACENE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-10 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ460</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>YG1024</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ400</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>DJ460</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>PREINCUBATION</methm>
<dosem>0-5 UG/PLATE</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[DUVERGER-VAN BOGAERT,M, DIERICKX,PJ AND CRUTZEN,MC; MUTAGENIC ACTIVATION OF AROMATIC AMINES BY A HUMAN HEPATOMA CELL (HEP G2) SUPERNATANT TESTED BY MEANS OF SALMONELLA TYPHIMURIUM STRAINS WITH DIFFERENT ACETYLTRANSFERASE ACTIVITIES; MUTAT. RES. 335(3):219-227, 1995]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-100 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[LAKE,BG, BEAMAND,JA, WIELD,PT AND PRICE,RJ;USE OF PRECISION-CUT LIVER SLICES TO EVALUATE SPECIES DIFFERENCES IN 2-ACETYLAMIMOFLUORENE-INDUCED UNSCHEDULED DNA SYNTHESIS; TOXICOL. APPL. PHARMACOL. 138(2):231-241, 1996]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>AROCLOR 1254</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-100 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[LAKE,BG, BEAMAND,JA, WIELD,PT AND PRICE,RJ;USE OF PRECISION-CUT LIVER SLICES TO EVALUATE SPECIES DIFFERENCES IN 2-ACETYLAMIMOFLUORENE-INDUCED UNSCHEDULED DNA SYNTHESIS; TOXICOL. APPL. PHARMACOL. 138(2):231-241, 1996]</ref></mstu>
<mstu><tsstm>UDS GUINEA PIG HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-100 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[LAKE,BG, BEAMAND,JA, WIELD,PT AND PRICE,RJ;USE OF PRECISION-CUT LIVER SLICES TO EVALUATE SPECIES DIFFERENCES IN 2-ACETYLAMIMOFLUORENE-INDUCED UNSCHEDULED DNA SYNTHESIS; TOXICOL. APPL. PHARMACOL. 138(2):231-241, 1996]</ref></mstu>
<mstu><tsstm>UDS MONKEY HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-100 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[LAKE,BG, BEAMAND,JA, WIELD,PT AND PRICE,RJ;USE OF PRECISION-CUT LIVER SLICES TO EVALUATE SPECIES DIFFERENCES IN 2-ACETYLAMIMOFLUORENE-INDUCED UNSCHEDULED DNA SYNTHESIS; TOXICOL. APPL. PHARMACOL. 138(2):231-241, 1996]</ref></mstu>
<mstu><tsstm>UDS HUMAN HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-100 MICROMOLAR (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[LAKE,BG, BEAMAND,JA, WIELD,PT AND PRICE,RJ;USE OF PRECISION-CUT LIVER SLICES TO EVALUATE SPECIES DIFFERENCES IN 2-ACETYLAMIMOFLUORENE-INDUCED UNSCHEDULED DNA SYNTHESIS; TOXICOL. APPL. PHARMACOL. 138(2):231-241, 1996]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER OVARY</tsstm>
<indcm>AS52/6-THIOGUANINE</indcm>
<matvm>NONE</matvm>
<dosem>30 MICROMOLAR</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BITSCH,A, FECHER,J, JOST,M, KLOHN,PC AND NEUMANN,HG; GENOTOXIC AND CHRONIC TOXIC EFFECTS IN THE CARCINOGENICITY OF AROMATIC AMINES; RECENT RESULTS CANCER RES. 143(RISK AND PROGRESSION FACTORS IN CARCINOGENESIS):209-223, 1997]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER OVARY</tsstm>
<indcm>AS52/6-THIOGUANINE</indcm>
<matvm>RAT LIVER S-9, 2-ACETYLAMINOFLUORENE</matvm>
<dosem>30 MICROMOLAR</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[BITSCH,A, FECHER,J, JOST,M, KLOHN,PC AND NEUMANN,HG; GENOTOXIC AND CHRONIC TOXIC EFFECTS IN THE CARCINOGENICITY OF AROMATIC AMINES; RECENT RESULTS CANCER RES. 143(RISK AND PROGRESSION FACTORS IN CARCINOGENESIS):209-223, 1997]</ref></mstu>
<mstu><tsstm>UDS RAT HEPATOCYTES</tsstm>
<indcm>THY INCORP</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION</methm>
<dosem>0.1-100 MICROMOLAR</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[KIM,DH, KIM,BR AND YANG,KH; DETECTION OF DNA SINGLE-STRAND BREAKS AND UNSCHEDULED DNA SYNTHESIS INDUCED BY PROCARCINOGENS IN PRIMARY CULTURES OF RAT HEPATOCYTES; KOREAN J. TOXICOL. 2(1):1-7, 1986]</ref></mstu>
<mstu><tsstm>UDS</tsstm>
<indcm>HEPG2/THYMIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>0.05-1 MICROMOLAR</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[VALENTIN-SEVERIN,I THYBAUD,V LE BON,AM LHUGUENOT,JC AND CHAGNON,MC; THE AUTORADIOGRAPHIC TEST FOR UNSCHEDULED DNA SYNTHESIS: A SENSITIVE ASSAY FOR THE DETECTION OF DNA REPAIR IN THE HEPG2 CELL LINE; MUTAT. RES. 559(1-2):211-217, 2004]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>AHH-1 CELLS</tsstm>
<matvm>NONE</matvm>
<dosem>3-100 UG/ML</dosem>
<dosrm>18 HR TREATMENT; CYTOCHALASIN B ADDED AT BEGINNING OF TREATMENT</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[CROFOTON-SLEIGH,C DOHERTY,A ELLARD,S PARRY,EM AND VENITT,S;   MUCRONUCLUES ASSAY USING CYTOCHALASIN-BLOCKED MCL-5 CELLS, A   PROPRIETARY HUMAN CELL LINE EXPRESSING FIVE HUMAN   CYTOCHROMASE P-450 AND MICROSOMAL EPOXIDE HYDROLASE;   MUTAGENESIS 8(4):363-372, 1993]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>MCL-5 CELLS</tsstm>
<matvm>NONE</matvm>
<dosem>3-100 UG/ML</dosem>
<dosrm>24 HR TREATMENT; CYTOCHALASIN B ADDED AT BEGINNING OF TREATMENT</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[CROFOTON-SLEIGH,C DOHERTY,A ELLARD,S PARRY,EM AND VENITT,S;   MUCRONUCLUES ASSAY USING CYTOCHALASIN-BLOCKED MCL-5 CELLS, A   PROPRIETARY HUMAN CELL LINE EXPRESSING FIVE HUMAN   CYTOCHROMASE P-450 AND MICROSOMAL EPOXIDE HYDROLASE;   MUTAGENESIS 8(4):363-372, 1993]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>V79 CELLS</tsstm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<dosem>0.1-100 UG/ML (TEST MATERIAL SOLVENT: DMSO)</dosem>
<dosrm>3 HR TREATMENT, 21 HR RECOVERY</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[VON DER HUDE,W KALWEIT,S ENGELHARDT,G MCKIERNAN,S KASPER,P  SLACIK-ERBEN,R MILTENBURGER,HG HONARVAR,N FAHRIG,R GORLITZ,B  ALBERTINI,S KIRCHNER,S UTESCH,D POTTER-LOCHER,F STOPPER,H  AND MADLE,S; IN VITRO MICRONUCLEUS ASSAY WITH CHINESE  HAMSTER V79 CELLS-RESULTS OF A COLLABORATIVE STUDY WITH IN  SITU EXPOSURE TO 26 CHEMICAL SUBSTANCES; MUTAT. RES.  468(2):137-163, 2000]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>V79 CELLS</tsstm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<dosem>0.5-500 UG/ML (TEST MATERIAL SOLVENT: DMSO)</dosem>
<dosrm>3 HR TREATMENT, 21 HR RECOVERY</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[VON DER HUDE,W KALWEIT,S ENGELHARDT,G MCKIERNAN,S KASPER,P  SLACIK-ERBEN,R MILTENBURGER,HG HONARVAR,N FAHRIG,R GORLITZ,B  ALBERTINI,S KIRCHNER,S UTESCH,D POTTER-LOCHER,F STOPPER,H  AND MADLE,S; IN VITRO MICRONUCLEUS ASSAY WITH CHINESE  HAMSTER V79 CELLS-RESULTS OF A COLLABORATIVE STUDY WITH IN  SITU EXPOSURE TO 26 CHEMICAL SUBSTANCES; MUTAT. RES.  468(2):137-163, 2000]</ref></mstu>
<mstu><endpm>In vivo micronucleus</endpm>
<tsstm>Micronucleated hepatocytes</tsstm>
<specm>Rat</specm>
<stsxm>F344/Male</stsxm>
<routm>Oral</routm>
<dosem>0; 125; 250; 500 mg/kg (Test material solvent: Oil suspension)</dosem>
<dosrm>Twice; Samples collected at 3, 4, or 5 days</dosrm>
<rsltm>Positive (p&lt;0.01 at highest dose)</rsltm>
<ref>[SUZUKI,H TAKASAWA,H KOBAYASHI,K TERASHIMA,Y SHIMADA,Y OGAWA,I TANAKA,J IMAMURA,T MIYAZAKI,A AND HAYASHI,M; EVALUATION OF A LIVER MICRONUCLEUS ASSAY WITH 12 CHEMICALS USING YOUNG RATS (II): A STUDY BY THE COLLABORATIVE STUDY GROUP FOR THE MICRONUCLEUS TEST/JAPANESE ENVIRONMENTAL MUTAGEN SOCIETY-MAMMALIAN MUTAGENICITY STUDY GROUP; MUTAGENESIS 24(1):9-16, 2008]</ref></mstu>
<mstu><endpm>In vivo micronucleus</endpm>
<tsstm>Micronucleated hepatocytes</tsstm>
<specm>Rat</specm>
<stsxm>F344/Male</stsxm>
<routm>Oral</routm>
<dosem>0; 500; 750 mg/kg (Test material solvent: Oil suspension)</dosem>
<dosrm>Once; Samples collected at 3, 4, or 5 days (500 mg/kg dose) or 4, 5, or 6 days (750 mg/kg dose)</dosrm>
<rsltm>Positive (p&lt;0.05 at lower dose and p&lt;0.01 at higher dose)</rsltm>
<ref>[SUZUKI,H TAKASAWA,H KOBAYASHI,K TERASHIMA,Y SHIMADA,Y OGAWA,I TANAKA,J IMAMURA,T MIYAZAKI,A AND HAYASHI,M; EVALUATION OF A LIVER MICRONUCLEUS ASSAY WITH 12 CHEMICALS USING YOUNG RATS (II): A STUDY BY THE COLLABORATIVE STUDY GROUP FOR THE MICRONUCLEUS TEST/JAPANESE ENVIRONMENTAL MUTAGEN SOCIETY-MAMMALIAN MUTAGENICITY STUDY GROUP; MUTAGENESIS 24(1):9-16, 2008]</ref></mstu>
<ccn>$null</ccn>
<commi>$null</commi>
<crcni>$null</crcni>
<docai>$null</docai>
<doini>$null</doini>
<dopri>$null</dopri>
<endii>$null</endii>
<endli>$null</endli>
<endmi>$null</endmi>
<noat>$null</noat>
<prmti>$null</prmti>
<rtcai>$null</rtcai>
<rtini>$null</rtini>
<rtpri>$null</rtpri>
<speci>$null</speci>
<stsxi>$null</stsxi>
<tttli>$null</tttli>
<use>$null</use>
</DOC>
<DOC>
<DOCNO>2</DOCNO>
<date>20080605</date>
<rln>1053</rln>
<DateRevised>Complete Update on 2008-06-05</DateRevised>
<DateRevised>Complete Update on 2006-02-02</DateRevised>
<DateRevised>Complete Update on 2004-04-23</DateRevised>
<DateRevised>Complete Update on 2004-04-23</DateRevised>
<DateRevised>Complete Update on 11/16/1989, 4 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/31/1985</DateRevised>
<NameOfSubstance>ACETAMIDE</NameOfSubstance>
<CASRegistryNumber>60-35-5</CASRegistryNumber>
<use>INTERMEDIATES; SOLVENTS</use>
<dtyp>Carcinogenicity</dtyp>
<dtyp>Mutagenicity</dtyp>
<cstu>
<specc>RAT</specc>
<stsxc>WISTAR/MALE</stsxc>
<routc>ORAL</routc>
<dosec>1.25; 2.5; 5% IN DIET FOR ONE YR</dosec>
<tstlc>LIVER: TRABECULAR CARCINOMA, ADENOCARCINOMA, HEPATOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[IARC MONOGRAPHS ON THE EVALUATION OF THE CARCINOGENIC RISK OF CHEMICALS TO HUMANS, INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, LYON, FRANCE, p. V7 197 Y74]</ref></cstu>
<mstu>
<tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50-1000 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DYBING,E, SOEDERLUND,EJ, GORDON,WP, HOLME,JA, CHRISTENSEN,T, BECHER,G, RIVEDAL,E AND THORGEIRSSON,SS; STUDIES ON THE MECHANISM OF ACETAMIDE HEPATOCARCINOGENICITY; PHARMACOL. TOXICOL. 60(1):9-16, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50-1000 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DYBING,E, SOEDERLUND,EJ, GORDON,WP, HOLME,JA, CHRISTENSEN,T, BECHER,G, RIVEDAL,E AND THORGEIRSSON,SS; STUDIES ON THE MECHANISM OF ACETAMIDE HEPATOCARCINOGENICITY; PHARMACOL. TOXICOL. 60(1):9-16, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50-1000 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DYBING,E, SOEDERLUND,EJ, GORDON,WP, HOLME,JA, CHRISTENSEN,T, BECHER,G, RIVEDAL,E AND THORGEIRSSON,SS; STUDIES ON THE MECHANISM OF ACETAMIDE HEPATOCARCINOGENICITY; PHARMACOL. TOXICOL. 60(1):9-16, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>50-1000 UG/PLATE</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DYBING,E, SOEDERLUND,EJ, GORDON,WP, HOLME,JA, CHRISTENSEN,T, BECHER,G, RIVEDAL,E AND THORGEIRSSON,SS; STUDIES ON THE MECHANISM OF ACETAMIDE HEPATOCARCINOGENICITY; PHARMACOL. TOXICOL. 60(1):9-16, 1987]</ref></mstu>
<mstu><endpm>IN VIVO MICRONUCLEUS</endpm>
<tsstm>BLOOD ERYTHROCYTES</tsstm>
<specm>MOUSE</specm>
<stsxm>CD-1/MALE</stsxm>
<routm>INTRAPERITONEAL INJECTION</routm>
<dosem>500, 1000, 2000 MG/KG</dosem>
<dosrm>SINGLE DOSE; HARVEST AT 48 AND 72 HR</dosrm>
<rsltm>NEGATIVE</rsltm>
<ref>[DE BOECK,M, VAN DER LEEDE,BJ, VAN GOETHEM,F, DE SMEDT,A, STEEMANS,M, LAMPO,A AND VANPARYS,P; FLOW CYTOMETRIC ANALYSIS OF MICRONUCLEATED RETICULOCYTES: TIME-AND DOSE-DEPENDENT RESPONSE OF KNOWN MUTAGENS IN MICE, USING MULTIPLE BLOOD SAMPLING; ENVIRON. MOL. MUTAGEN. 46(1):30-42, 2005]</ref></mstu>
<mstu><tsstm>Ames Salmonella typhimurium</tsstm>
<indcm>YG7108pin3ERb5</indcm>
<matvm>None</matvm>
<methm>Standard plate</methm>
<dosem>0-10,000 ug/plate (Test material solvent: water)</dosem>
<rsltm>Negative</rsltm>
<ref>[EMMERT,B BUENGER,J, KEUCH,K, MUELLER,M, EMMERT,S, HALLIER,E AND WESTPHAL,GA; MUTAGENICITY OF CYTOCHROME P450 2E1 SUBSTRATES IN THE AMES TEST WITH THE METABOLIC COMPETENT S. TYPHIMURIUM STRAIN YG7108PIN3ERB5; TOXICOLOGY 228(1):66-76, 2006]</ref></mstu>
<ccn>$null</ccn>
<commi>$null</commi>
<crcni>$null</crcni>
<crcnt>$null</crcnt>
<docai>$null</docai>
<docat>$null</docat>
<doini>$null</doini>
<dopri>$null</dopri>
<doprt>$null</doprt>
<endii>$null</endii>
<endli>$null</endli>
<endmi>$null</endmi>
<noat>$null</noat>
<prmti>$null</prmti>
<rtcai>$null</rtcai>
<rtcat>$null</rtcat>
<rtini>$null</rtini>
<rtpri>$null</rtpri>
<rtprt>$null</rtprt>
<speci>$null</speci>
<spect>$null</spect>
<stsxi>$null</stsxi>
<stsxt>$null</stsxt>
<tttli>$null</tttli>
<tttlt>$null</tttlt>
</DOC>
<DOC>
<DOCNO>3</DOCNO>
<date>20100602</date>
<rln>12192</rln>
<DateRevised>Complete Update on 2010-06-02</DateRevised>
<DateRevised>Complete Update on 2006-12-04</DateRevised>
<DateRevised>Complete Update on 2006-06-05</DateRevised>
<DateRevised>Complete Update on 2006-05-04</DateRevised>
<DateRevised>Complete Update on 07/22/2003, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 06/25/2001, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 06/12/1997, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 02/02/1996, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 10/02/1995, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 09/01/1995, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 08/02/1995, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 09/10/1993, 3 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 03/19/1993, 4 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 02/21/1992, 1 field added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 10/19/1989, 4 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/31/1985</DateRevised>
<NameOfSubstance>ACETAMINOPHEN</NameOfSubstance>
<CASRegistryNumber>103-90-2</CASRegistryNumber>
<dtyp>Carcinogenicity</dtyp>
<dtyp>Mutagenicity</dtyp>
<dtyp>Tumor Inhibition</dtyp>
<cstu>
<specc>MOUSE</specc>
<stsxc>STRAIN-IF/MALE,FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0.5; 1.0% IN DIET FOR 18 MO</dosec>
<tstlc>LIVER: HEPATOCELLULAR ADENOMA, CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[FLAKS,A AND FLAKS,B; INDUCTION OF LIVER CELL TUMOURS IN IF MICE BY PARACETAMOL; CARCINOGENESIS 4:363-368, 1983]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 600; 3000; 6000 PPM IN DIET FOR 103 WK (STUDY DURATION: 106 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>B6C3F1/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 600; 3000; 6000 PPM IN DIET FOR 103 WK (STUDY DURATION: 106 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>B6C3F1/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 600; 3000; 6000 PPM IN DIET FOR 103 WK (STUDY DURATION: 106 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 0.45; 0.9% IN DIET FOR 104 WK (STUDY DURATION: 130 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[HIRAGA,K AND FUJII,T; CARCINOGENICITY TESTING OF ACETAMINOPHEN IN F344 RATS; JPN. J. CANCER RES. (GANN) 76(2):79-85, 1985]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 0.65; 1.3% IN DIET FOR 104 WK (STUDY DURATION: 130 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[HIRAGA,K AND FUJII,T; CARCINOGENICITY TESTING OF ACETAMINOPHEN IN F344 RATS; JPN. J. CANCER RES. (GANN) 76(2):79-85, 1985]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>STRAIN-IF/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 0.5; 1% IN DIET FOR 18 MO (STUDY DURATION: 18 MO)</dosec>
<tstlc>LIVER: HEPATOCELLULAR CARCINOMA, HEPATOCELLULAR ADENOMA OR CARCINOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[FLAKS,A AND FLAKS,B; INDUCTION OF LIVER CELL TUMOURS IN IF MICE BY PARACETAMOL; CARCINOGENESIS 4:363-368, 1983]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>STRAIN-IF/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 0.5; 1% IN DIET FOR 18 MO (STUDY DURATION: 18 MO)</dosec>
<tstlc>LIVER: HEPATOCELLULAR CARCINOMA OR ADENOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[FLAKS,A AND FLAKS,B; INDUCTION OF LIVER CELL TUMOURS IN IF MICE BY PARACETAMOL; CARCINOGENESIS 4:363-368, 1983]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>B6C3F1/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 5000; 10000 PPM IN DIET BEGINNING AT 6 WK OF AGE AND CONTINUING FOR 70 WK (STUDY DURATION: 72 WK)</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[HAGIWARA,A AND WARD,JM; THE CHRONIC HEPATOTOXIC, TUMOR-PROMOTING, AND CARCINOGENIC EFFECTS OF ACETAMINOPHEN IN MALE B6C3F1 MICE; FUNDAM. APPL. TOXICOL. 7:376-386, 1986]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 600; 3000; 6000 PPM IN DIET FOR 103 WK (STUDY DURATION: 106 WK)</dosec>
<tstlc>MULTIPLE ORGANS: MONONUCLEAR CELL LEUKEMIA</tstlc>
<rsltc>EQUIVOCAL</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></cstu>
<mstu>
<tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA97</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA97</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0.1-50 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[JASIEWICZ,ML AND RICHARDSON,JC; ABSENCE OF MUTAGENIC ACTIVITY OF BENORYLATE, PARACETAMOL AND ASPIRIN IN THE SALMONELLA/MAMMALIAN MICROSOME TEST; MUTAT. RES. 190(2):95-100, 1987]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>TEST SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>5-5000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[OLDHAM,JW, PRESTON,RF AND PAULSON,JD; MUTAGENICITY TESTING OF SELECTED ANALGESICS IN AMES SALMONELLA STRAINS; J. APPL. TOXICOL. 6(4):237-243, 1986]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254 (10%)</matvm>
<methm>PREINCUBATION</methm>
<dosem>100-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-394 Y93]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>GUINEA PIG, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>GUINEA PIG, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, PCB</matvm>
<methm>PREINCUBATION</methm>
<dosem>0.1-10 MG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>POSITIVE</rsltm>
<ref>[KUBOYAMA,N AND FUJII,A; MUTAGENICITY OF ANALGESICS, THEIR DERIVATIVES, AND ANTI-INFLAMMATORY DRUGS WITH S-9 MIX OF SEVERAL ANIMAL SPECIES; J. NIHON UNIV. SCH. DENT. 34(3):183-195, 1992]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, PYRAZOLE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, PYRAZOLE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, PYRAZOLE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, PYRAZOLE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA102</indcm>
<matvm>RAT, LIVER, S-9, PYRAZOLE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, ETHANOL</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, ETHANOL</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA102</indcm>
<matvm>RAT, LIVER, S-9, ETHANOL</matvm>
<methm>STANDARD PLATE</methm>
<dosem>0-2500 UG/PLATE (TEST MATERIAL SOLVENT: METHANOL)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[BURKE,DA, WEDD,DJ, HERRIOTT,D, BAYLISS,MK, SPALDING,DJM AND WILCOX,P; EVALUATION OF PYRAZOLE AND ETHANOL INDUCED S9 FRACTION IN BACTERIAL MUTAGENICITY TESTING; MUTAGENESIS 9(1):23-29, 1994]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>PREINCUBATION</methm>
<rsltm>NEGATIVE</rsltm>
<ref>[NOHMI,T, ISHIDATE,M,JR, HIRATSUKA,A AND WATABE,T; MECHANISM OF METABOLIC ACTIVATION OF THE ANALGETIC BUCETIN TO BACTERIAL MUTAGENS BY HAMSTER LIVER MICROSOMES; CHEM. PHARM. BULL. 33(7):2877-2885]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, KANECHLOR 400</matvm>
<methm>PREINCUBATION</methm>
<dosem>NEGATIVE</dosem>
<ref>[NOHMI,T, ISHIDATE,M,JR, HIRATSUKA,A AND WATABE,T; MECHANISM OF METABOLIC ACTIVATION OF THE ANALGETIC BUCETIN TO BACTERIAL MUTAGENS BY HAMSTER LIVER MICROSOMES; CHEM. PHARM. BULL. 33(7):2877-2885]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>CHL/IU CELLS</tsstm>
<matvm>NONE</matvm>
<dosem>15-120 UG/ML (TEST MATERIAL SOLVENT: SALINE)</dosem>
<dosrm>48 HR CONTINUOUS TREATMENT</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[MATSUSHIMA,T HAYASHI,M MATSUOKA,A ISHIDATE,M MIURA,KF SHIMIZU,H SUZUKI,Y MORIMOTO,K OGURA MURE,K KOSHI,K AND SOFUNI,T; VALIDATION OF THE IN VITRO MICRONUCLEUS TEST IN A CHINESE HAMSTER LUNG CELL LINE (CHL/IU); MUTAGENESIS 14(6):569-580, 1999]</ref></mstu>
<mstu><endpm>IN VITRO MICRONUCLEUS</endpm>
<tsstm>RAT KIDNEY FIBROBLAST NRK-49F</tsstm>
<matvm>NONE</matvm>
<dosem>5; 10; 20 MM</dosem>
<dosrm>1 HR INCUBATION</dosrm>
<rsltm>POSITIVE</rsltm>
<ref>[DUNN,TL, GARDINER,RA, SEYMOUR,GJ AND LAVIN,MF; GENOTOXICITY  OF ANALGESIC COMPOUNDS ASSESSED BY AN IN VITRO MICRONUCLEUS  ASSAY; MUTAT. RES. 189(3):299-306, 1987]</ref></mstu>
<istu>
<speci>RAT</speci>
<noat>(?,23)/(?,27)</noat>
<stsxi>F344/MALE</stsxi>
<doini>1.3% IN DIET BEGINNING 1 WK AFTER LAST CARCINOGEN TREATMENT AND CONTINUING THROUGH DURATION OF STUDY (STUDY DURATION: 32 WK)</doini>
<rtini>ORAL</rtini>
<crcni>N-ETHYL-N-HYDROXYETHYLNITROSAMINE ; 13147-25-6</crcni>
<rtcai>ORAL</rtcai>
<docai>0.1% IN DRINKING WATER FOR 2 WK AT BEGINNING OF STUDY</docai>
<prmti>NONE USED</prmti>
<tttli>LIVER: HEPATOCELLULAR CARCINOMA</tttli>
<endii>11/23 (48%), 3/27 (11%), 77%, P&lt;0.05</endii>
<commi>NUMBER OF RATS WITH HYPERPLASTIC NODULES (22/23, 20/27, P&lt;0.05) AND NUMBER HYPERPLASTIC NODULES/CM2 (1.9, 1.5, P&lt;0.001) SIGNIFICANTLY DIFFERENT BETWEEN CARCINOGEN CONTROL AND CARCINOGEN + INHIBITOR, BHA SIGNIFICANTLY (P&lt;0.05, P&lt;0.001) REDUCED THESE PARAMETERS</commi>
<ref>[TSUDA,H, SAKATA,T, MASUI,T, IMAIDA,K AND ITO,N; MODIFYING EFFECTS OF BUTYLATED HYDROXYANISOLE, ETHOXYQUIN AND ACETAMINOPHEN ON INDUCTION OF NEOPLASTIC LESIONS IN RAT LIVER AND KIDNEY INITIATED BY N-ETHYL-N-HYDROXYETHYLNITROSAMINE; CARCINOGENESIS 5(4):525-531, 1984]</ref></istu>
<istu><speci>RAT</speci>
<noat>(?,23)/(?,27)</noat>
<stsxi>F344/MALE</stsxi>
<doini>1.3% IN DIET BEGINNING 1 WK AFTER LAST CARCINOGEN TREATMENT AND CONTINUING THROUGH DURATION OF STUDY (STUDY DURATION: 32 WK)</doini>
<rtini>ORAL</rtini>
<crcni>N-ETHYL-N-HYDROXYETHYLNITROSAMINE ; 13147-25-6</crcni>
<rtcai>ORAL</rtcai>
<docai>0.1% IN DRINKING WATER FOR 2 WK AT BEGINNING OF STUDY</docai>
<prmti>NONE USED</prmti>
<tttli>KIDNEY: ADENOMA</tttli>
<endii>5/23 (22%), 15/27 (56%), -154%, P&lt;0.01</endii>
<endmi>0.08, 0.54, -575%, P&lt;0.01</endmi>
<commi>MULTIPLICITY DATA REPORTED AS NUMBER OF TUMORS/CM2</commi>
<ref>[TSUDA,H, SAKATA,T, MASUI,T, IMAIDA,K AND ITO,N; MODIFYING EFFECTS OF BUTYLATED HYDROXYANISOLE, ETHOXYQUIN AND ACETAMINOPHEN ON INDUCTION OF NEOPLASTIC LESIONS IN RAT LIVER AND KIDNEY INITIATED BY N-ETHYL-N-HYDROXYETHYLNITROSAMINE; CARCINOGENESIS 5(4):525-531, 1984]</ref></istu>
<istu><speci>RAT</speci>
<noat>(?,23)/(?,27)</noat>
<stsxi>F344/MALE</stsxi>
<doini>1.3% IN DIET BEGINNING 1 WK AFTER LAST CARCINOGEN TREATMENT AND CONTINUING THROUGH DURATION OF STUDY (STUDY DURATION: 32 WK)</doini>
<rtini>ORAL</rtini>
<crcni>N-ETHYL-N-HYDROXYETHYLNITROSAMINE ; 13147-25-6</crcni>
<rtcai>ORAL</rtcai>
<docai>0.1% IN DRINKING WATER FOR 2 WK AT BEGINNING OF STUDY</docai>
<prmti>NONE USED</prmti>
<tttli>KIDNEY: ADENOCARCINOMA</tttli>
<endii>0/23 (0%), 1/23 (4%), NOT SIGNIFICANT</endii>
<ref>[TSUDA,H, SAKATA,T, MASUI,T, IMAIDA,K AND ITO,N; MODIFYING EFFECTS OF BUTYLATED HYDROXYANISOLE, ETHOXYQUIN AND ACETAMINOPHEN ON INDUCTION OF NEOPLASTIC LESIONS IN RAT LIVER AND KIDNEY INITIATED BY N-ETHYL-N-HYDROXYETHYLNITROSAMINE; CARCINOGENESIS 5(4):525-531, 1984]</ref></istu>
<istu><speci>MOUSE</speci>
<noat>(?,29)/(25,25)</noat>
<stsxi>STRAIN-A/FEMALE</stsxi>
<doini>0; 1520 MMOL/KG BW/D IN DIET FOR DURATION OF STUDY BEGINNING 2 WK PRIOR TO CARCINOGEN TREATMENT (STUDY DURATION: 25 WK)</doini>
<rtini>ORAL</rtini>
<crcni>4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; 64091-91-4</crcni>
<rtcai>ORAL</rtcai>
<docai>2.2 MMOL/KG BW (TOTAL DOSE) ADMINISTERED IN DRINKING WATER FOR 7 WK</docai>
<prmti>NONE USED</prmti>
<tttli>LUNG:TUMOR</tttli>
<endii>29/29 (100%), 25/25 (100%), 0%, NOT SIGNIFICANT</endii>
<endmi>8.7, 6.5, 25%, NOT SIGNIFICANT</endmi>
<ref>[RIOUX,N AND CASTONGUAY,A; PREVENTION OF NNK-INDUCED LUNG TUMORIGENESIS IN A/J MICE BY ACETYLSALICYLIC ACID AND NS-398; CANCER RES. 58(23):5354-5360, 1998]</ref></istu>
<ccn>$null</ccn>
<crcnt>$null</crcnt>
<docat>$null</docat>
<dopri>$null</dopri>
<doprt>$null</doprt>
<endli>$null</endli>
<routm>$null</routm>
<rtcat>$null</rtcat>
<rtpri>$null</rtpri>
<rtprt>$null</rtprt>
<specm>$null</specm>
<spect>$null</spect>
<stsxm>$null</stsxm>
<stsxt>$null</stsxt>
<tttlt>$null</tttlt>
<use>$null</use>
</DOC>
<DOC>
<DOCNO>4</DOCNO>
<date>19940701</date>
<rln>35435</rln>
<DateRevised>Complete Update on 07/01/1994, 4 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/31/1985</DateRevised>
<NameOfSubstance>ACETOHEXAMIDE</NameOfSubstance>
<CASRegistryNumber>968-81-0</CASRegistryNumber>
<dtyp>Carcinogenicity</dtyp>
<dtyp>Mutagenicity</dtyp>
<cstu>
<specc>MOUSE</specc>
<stsxc>B6C3F1/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 6359; 12718 PPM IN DIET, TWA</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-50 Y78]</ref></cstu>
<cstu><specc>MOUSE</specc>
<stsxc>B6C3F1/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 6359; 12718 PPM IN DIET, TWA</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-50 Y78]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/FEMALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 10000; 20000 PPM IN DIET</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-50 Y78]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>F344/MALE</stsxc>
<routc>ORAL</routc>
<dosec>0; 10000; 20000 PPM IN DIET</dosec>
<rsltc>NEGATIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-50 Y78]</ref></cstu>
<mstu>
<tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>10-10000 UG/PLATE (TEST MATERIAL SOLVENT: DMSO)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA98</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA100</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1535</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1538</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>AMES SALMONELLA TYPHIMURIUM</tsstm>
<indcm>TA1537</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>33.3-10000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>NONE</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>RAT, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>MOUSE, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>MOUSE, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>HAMSTER, LIVER, S-9</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<mstu><tsstm>E. COLI</tsstm>
<indcm>WP2 UVRA</indcm>
<matvm>HAMSTER, LIVER, S-9, AROCLOR 1254</matvm>
<methm>STANDARD PLATE</methm>
<dosem>3.3-1000 UG/PLATE (TEST MATERIAL SOLVENT: ACETONE)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[DUNKEL,VC, ZEIGER,E, BRUSICK,D, MCCOY,E, MCGREGOR,D, MORTELMANS,K, ROSENKRANZ, HS AND SIMMON,VF; REPRODUCIBILITY OF MICROBIAL MUTAGENICITY ASSAYS: II. TESTING OF CARCINOGENS AND NONCARCINOGENS IN SALMONELLA TYPHIMURIUM AND ESCHERICHIA COLI; ENVIRON. MOL. MUTAGEN. 7(SUPPL. 5):1-248, 1985]</ref></mstu>
<ccn>$null</ccn>
<commi>$null</commi>
<crcni>$null</crcni>
<crcnt>$null</crcnt>
<docai>$null</docai>
<docat>$null</docat>
<doini>$null</doini>
<dopri>$null</dopri>
<doprt>$null</doprt>
<dosrm>$null</dosrm>
<endii>$null</endii>
<endli>$null</endli>
<endmi>$null</endmi>
<endpm>$null</endpm>
<noat>$null</noat>
<prmti>$null</prmti>
<routm>$null</routm>
<rtcai>$null</rtcai>
<rtcat>$null</rtcat>
<rtini>$null</rtini>
<rtpri>$null</rtpri>
<rtprt>$null</rtprt>
<speci>$null</speci>
<specm>$null</specm>
<spect>$null</spect>
<stsxi>$null</stsxi>
<stsxm>$null</stsxm>
<stsxt>$null</stsxt>
<tstlc>$null</tstlc>
<tttli>$null</tttli>
<tttlt>$null</tttlt>
<use>$null</use>
</DOC>
<DOC>
<DOCNO>5</DOCNO>
<date>20010625</date>
<rln>2901</rln>
<DateRevised>Complete Update on 06/25/2001, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 05/28/1993, 2 fields added/edited/deleted.</DateRevised>
<DateRevised>Complete Update on 12/31/1985</DateRevised>
<NameOfSubstance>ACETOXIME</NameOfSubstance>
<CASRegistryNumber>127-06-0</CASRegistryNumber>
<dtyp>Carcinogenicity</dtyp>
<dtyp>Mutagenicity</dtyp>
<cstu>
<specc>RAT</specc>
<stsxc>WISTAR/MALE</stsxc>
<routc>ORAL</routc>
<dosec>1.0 G/L IN DRINKING WATER 5/WK FOR 18 MO</dosec>
<tstlc>LIVER: HEPATOCELLULAR ADENOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[MIRVISH,SS, SALMASI,S AND RUNGE,RG; CARCINOGENICITY TEST OF ACETOXIME IN MRC-WISTAR RATS; J. NATL. CANCER INST. 69:961-962, 1982]</ref></cstu>
<mstu>
<tsstm>UDS RODENT HEPATOCYTES</tsstm>
<indcm>THY INCORP (NON-S-PHASE)</indcm>
<matvm>NONE</matvm>
<methm>LIQUID SCINTILLATION COUNTING</methm>
<dosem>0-3 MILLIMOLAR</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HAAS-JOBELIUS,M, ZIEGLER-SKYLAKAKIS,K AND ANDRAE,U; NITROREDUCTION IS NOT INVOLVED IN THE GENOTOXICITY OF 2-NITROPROPANE IN CULTURED MAMMALIAN CELLS; MUTAGENESIS 6(1):87-91, 1991]</ref></mstu>
<mstu><tsstm>CHINESE HAMSTER V-79</tsstm>
<indcm>V-79/6-THIOGUANINE</indcm>
<matvm>NONE</matvm>
<methm>SUSPENSION</methm>
<dosem>0-5 MILLIMOLAR</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[HAAS-JOBELIUS,M, ZIEGLER-SKYLAKAKIS,K AND ANDRAE,U; NITROREDUCTION IS NOT INVOLVED IN THE GENOTOXICITY OF 2-NITROPROPANE IN CULTURED MAMMALIAN CELLS; MUTAGENESIS 6(1):87-91, 1991]</ref></mstu>
<mstu><tsstm>UDS CHINESE HAMSTER V-79 CELLS</tsstm>
<indcm>V-79-MZ/CYTIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-10 MM (TEST MATERIAL SOLVENT: EARLE'S MEDIUM)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[ANDRAE,U KREIS,P COUGHTRIE,MWH PABEL,U MEINL,W BARTSCH,I AND GLATT,H; ACTIVATION OF PROPANE 2-NITRONATE TO A GENOTOXICANT IN V-79-DERIVED CELL LINES ENGINEERED FOR THE EXPRESSION OF RAT HEPATIC SULFOTRANSFERASES; MUTAT. RES. 439(2):191-197, 1999]</ref></mstu>
<mstu><tsstm>UDS CHINESE HAMSTER V-79 CELLS</tsstm>
<indcm>V-79-RHSTA/CYTIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-10 MM (TEST MATERIAL SOLVENT: EARLE'S MEDIUM)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[ANDRAE,U KREIS,P COUGHTRIE,MWH PABEL,U MEINL,W BARTSCH,I AND GLATT,H; ACTIVATION OF PROPANE 2-NITRONATE TO A GENOTOXICANT IN V-79-DERIVED CELL LINES ENGINEERED FOR THE EXPRESSION OF RAT HEPATIC SULFOTRANSFERASES; MUTAT. RES. 439(2):191-197, 1999]</ref></mstu>
<mstu><tsstm>UDS CHINESE HAMSTER V-79 CELLS</tsstm>
<indcm>V-79-RHST20/CYTIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-10 MM (TEST MATERIAL SOLVENT: EARLE'S MEDIUM)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[ANDRAE,U KREIS,P COUGHTRIE,MWH PABEL,U MEINL,W BARTSCH,I AND GLATT,H; ACTIVATION OF PROPANE 2-NITRONATE TO A GENOTOXICANT IN V-79-DERIVED CELL LINES ENGINEERED FOR THE EXPRESSION OF RAT HEPATIC SULFOTRANSFERASES; MUTAT. RES. 439(2):191-197, 1999]</ref></mstu>
<mstu><tsstm>UDS CHINESE HAMSTER V-79 CELLS</tsstm>
<indcm>V-79-RST1C1/CYTIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-10 MM (TEST MATERIAL SOLVENT: EARLE'S MEDIUM)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[ANDRAE,U KREIS,P COUGHTRIE,MWH PABEL,U MEINL,W BARTSCH,I AND GLATT,H; ACTIVATION OF PROPANE 2-NITRONATE TO A GENOTOXICANT IN V-79-DERIVED CELL LINES ENGINEERED FOR THE EXPRESSION OF RAT HEPATIC SULFOTRANSFERASES; MUTAT. RES. 439(2):191-197, 1999]</ref></mstu>
<mstu><tsstm>UDS CHINESE HAMSTER V-79 CELLS</tsstm>
<indcm>V-79-RPST-IV/CYTIDINE INCORPORATION</indcm>
<matvm>NONE</matvm>
<methm>AUTORADIOGRAPHY</methm>
<dosem>1-10 MM (TEST MATERIAL SOLVENT: EARLE'S MEDIUM)</dosem>
<rsltm>NEGATIVE</rsltm>
<ref>[ANDRAE,U KREIS,P COUGHTRIE,MWH PABEL,U MEINL,W BARTSCH,I AND GLATT,H; ACTIVATION OF PROPANE 2-NITRONATE TO A GENOTOXICANT IN V-79-DERIVED CELL LINES ENGINEERED FOR THE EXPRESSION OF RAT HEPATIC SULFOTRANSFERASES; MUTAT. RES. 439(2):191-197, 1999]</ref></mstu>
<ccn>$null</ccn>
<commi>$null</commi>
<crcni>$null</crcni>
<crcnt>$null</crcnt>
<docai>$null</docai>
<docat>$null</docat>
<doini>$null</doini>
<dopri>$null</dopri>
<doprt>$null</doprt>
<dosrm>$null</dosrm>
<endii>$null</endii>
<endli>$null</endli>
<endmi>$null</endmi>
<endpm>$null</endpm>
<noat>$null</noat>
<prmti>$null</prmti>
<routm>$null</routm>
<rtcai>$null</rtcai>
<rtcat>$null</rtcat>
<rtini>$null</rtini>
<rtpri>$null</rtpri>
<rtprt>$null</rtprt>
<speci>$null</speci>
<specm>$null</specm>
<spect>$null</spect>
<stsxi>$null</stsxi>
<stsxm>$null</stsxm>
<stsxt>$null</stsxt>
<tttli>$null</tttli>
<tttlt>$null</tttlt>
<use>$null</use>
</DOC>
<DOC>
<DOCNO>6</DOCNO>
<date>19871117</date>
<rln>830</rln>
<DateRevised>Complete Update on 11/17/1987</DateRevised>
<NameOfSubstance>ACRONYCINE</NameOfSubstance>
<CASRegistryNumber>7008-42-6</CASRegistryNumber>
<use>DRUGS (ANTINEOPLASTICS)</use>
<dtyp>Carcinogenicity</dtyp>
<cstu>
<specc>RAT</specc>
<stsxc>SPRAGUE-DAWLEY/FEMALE</stsxc>
<routc>INTRAPERITONEAL</routc>
<dosec>0; 3.75; 7.5; 15 MG/KG FOR 52 WK (STUDY DURATION: 80-82 WK)</dosec>
<tstlc>MAMMARY GLAND: FIBROADENOMA; PERITONEAL CAVITY: SARCOMA OR FIBROSARCOMA OR MESOTHELIOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-49 Y78]</ref></cstu>
<cstu><specc>RAT</specc>
<stsxc>SPRAGUE-DAWLEY/MALE</stsxc>
<routc>INTRAPERITONEAL</routc>
<dosec>0; 3.75; 7.5; 15 MG/KG FOR 51-52 WK (STUDY DURATION: 51-82 WK)</dosec>
<tstlc>MUSCULOSKELETAL SYSTEM: OSTEOSARCOMA; PERITONEAL CAVITY: SARCOMA OR FIBROSARCOMA OR MESOTHELIOMA</tstlc>
<rsltc>POSITIVE</rsltc>
<ref>[NCI/NTP CARCINOGENESIS TECHNICAL REPORT SERIES; NATIONAL CANCER INSTITUTE/NATIONAL TOXICOLOGY PROGRAM; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, TR-49 Y78]</ref></cstu>
<ccn>$null</ccn>
<commi>$null</commi>
<crcni>$null</crcni>
<crcnt>$null</crcnt>
<docai>$null</docai>
<docat>$null</docat>
<doini>$null</doini>
<dopri>$null</dopri>
<doprt>$null</doprt>
<dosem>$null</dosem>
<dosrm>$null</dosrm>
<endii>$null</endii>
<endli>$null</endli>
<endmi>$null</endmi>
<endpm>$null</endpm>
<indcm>$null</indcm>
<matvm>$null</matvm>
<methm>$null</methm>
<noat>$null</noat>
<prmti>$null</prmti>
<routm>$null</routm>
<rsltm>$null</rsltm>
<rtcai>$null</rtcai>
<rtcat>$null</rtcat>
<rtini>$null</rtini>
<rtpri>$null</rtpri>
<rtprt>$null</rtprt>
<speci>$null</speci>
<specm>$null</specm>
<spect>$null</spect>
<stsxi>$null</stsxi>
<stsxm>$null</stsxm>
<stsxt>$null</stsxt>
<tsstm>$null</tsstm>
<tttli>$null</tttli>
<tttlt>$null</tttlt>
</DOC>
</ccris>